Dr. Hans Keirstead is a renowned stem cell expert and entrepreneur, known for pioneering therapies in cancer, immune disorders, and motor neuron diseases. He founded several biotech firms, which were sold to major pharmaceutical companies, yielding returns of 2.5X-9.5X to investors. He holds board Chair or CEO positions in leading biotechs including AIVITA Biomedical, Immunis Inc., and the global non-profit, Human Immunome Project. During his 15-year tenure at the UC Irvine, Dr. Keirstead mentored >100 students, published >150 manuscripts, and granted >20 patents. His international media recognition includes being listed as one of Discover Magazine’s top 100 scientists, and highlights in WIRED, NY Times, TIME Magazine, Science, TEDx and more. His scientific accomplishments were covered on 60 Minutes, PBS, and ABC news radio. Dr. Keirstead’s notable awards include one of the Consul General of Canada’s “Top 20 Canadians,” Corporate LiveWire’s “Best Entrepreneur,” Octane’s “Best Technology Company CEO,” OCBJ’s “Innovator of the Year,” NIH Solowey award for “National Researcher of the Year,” and recognition as a world thought leader at the Seven Wonderer's event by Beakerhead. Dr. Keirstead received his Ph.D. in neuroscience from the University of British Columbia, Canada and pursued his postdoctoral research at the University of Cambridge, England.